Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2007

Conditions
Esophageal Neoplasms
Interventions
DRUG

FOLFOX 4

total treatment of six 2-weekly cycles of FOLFOX 4, the first 3 cycles starting on D1, D15 and D29 concomitant with 5 weeks' radiotherapy.

DRUG

5-FU / Cisplatin

two cycles of 5-FU / Cisplatin on week 1 and 5 of radiotherapy and two cycles of chemotherapy with 5-FU / Cisplatin on week 8 and 11 (one cycle each three weeks after the end of radiotherapy).

Trial Locations (1)

Unknown

Sanofi-Aventis, Paris

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY